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Abstract: Plasma technology has been widely used to increase the surface energy of the 
polymer surfaces for many industrial applications; in particular to increase in wettability. 
The present work was carried out to investigate how surface modification using plasma 
treatment modifies the surface energy of micro-injection moulded microneedles and its 
influence on drug delivery. Microneedles of polyether ether ketone and polycarbonate and 
have been manufactured using micro-injection moulding and samples from each 
production batch have been subsequently subjected to a range of plasma treatment. These 
samples were coated with bovine serum albumin to study the protein adsorption on these 
treated polymer surfaces. Sample surfaces structures, before and after treatment, were 
studied using atomic force microscope and surface energies have been obtained using 
contact angle measurement and calculated using the Owens-Wendt theory. Adsorption 
performance of bovine serum albumin and release kinetics for each sample set was 
assessed using a Franz diffusion cell. Results indicate that plasma treatment significantly 
increases the surface energy and roughness of the microneedles resulting in better 
adsorption and release of BSA. 
OPEN ACCESS
Pharmaceutics 2015, 7 472 
 
Keywords: plasma treatment; microneedle; micro-injection moulding; atomic force microscope; 
bovine serum albumin 
 
1. Introduction 
Puncturing human skin with hypodermic needles, which is an invasive medical procedure for 
injecting or collecting biological samples, has been universally accepted for many years [1,2]. Despite 
the widespread use, hypodermic needle mediated injections cause pain, related infections and 
sometimes bleeding [3,4]. It is estimated that over 15% of the world’s adult population suffer from 
trypanophobia (fear of hypodermic needles) [5]. For diabetic patients who are dependent on multiple 
insulin injections on a daily basis, drug delivery using conventional syringes is the most accepted  
route [6]. Patch-based transdermal drug delivery offers an alternative way to administer drugs without 
the drawbacks of the hypodermic needles, but the conventional transdermal drug delivery is limited to 
those drugs that can diffuse the skin barrier [7]. The outermost layer of the skin stratum corneum 
provides a significant barrier and only drugs with low molecular weight <500 Da and adequate 
lipophilicity can be successfully administered. Thus, delivery of hydrophilic drugs and 
macromolecular agents, like peptides and DNA, are cumbersome [8]. Therefore, facilitation of drug 
penetration through these biological membranes can only be achieved by reversible disruption of 
molecular structure of the barrier membranes [8,9]. However, current advances in micromanufacturing 
technologies offer a number of advantages over hypodermic needles and guided the formulation 
scientists to design micron-sized needles called microneedles (MNs) [10,11]. 
MNs consist of a plurality of micro-projections, ranging from 10 to 1800 µm in height and 
produced from number of different techniques like etching, lithographic, and moulding techniques to 
produce sharp, high aspect ratio, solid or hollow features in materials, such as plastics, silicon, 
ceramics, and metals [1,12,13]. MNs, when used to puncture skin will create a transient aqueous 
transport pathways of micron dimensions and improve permeability [1,14,15]. 
The emergence of microneedle technologies offers a route for a pain free, straightforward and 
efficient way of transdermal drug delivery, but technological barriers still exist which pose significant 
challenges for manufacture of MN systems with high volume outputs at low cost. The main aim of  
this research was to develop new ways for microneedle manufacture primarily using micro-injection 
moulding processes with high performance engineering thermoplastics. 
Despite the extraordinary versatility of most polymers for solid MN manufacturing, there is one 
property that markedly reduces its application: a highly hydrophobic surface [16–18]. This property 
makes it difficult to wet and coat the polymeric microneedle surfaces with proteins, vaccines and 
active pharmaceutical ingredients. These problems arise because the plastic surfaces have relatively 
poor wetting and adhesion properties, which are due to their low surface energy (absence of polar 
surface groups) [19,20]. Hence, surface modification of polymeric materials plays an important role to 
improve surface properties such as wetting and adhesion for coatings, inking and printing processes, 
biomaterials, and active pharmaceutical ingredients. A well-documented solution for this problem is 
the use of surface modification of polymer surfaces to increase surface energy. 
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Various other modification techniques such as, UV irradiation, laser, chemical oxidation, flame and 
grafting have attracted much attention [21]. Plasma methods are more attractive for many reason like 
they restrict the surface modifications to depth of several nanometers of the specimen while 
maintaining its bulk properties, desired surface polarities can be achieved, their low temperature avoids 
sample destruction [22]. The plasma used for these applications, although not fully ionized, are 
composed of ions, free electrons, photons, neutral atoms and molecules in ground and excited 
electronic states [23]. Each of these components has the potential for interaction with surfaces with 
which they come in contact. The surface wetting and adhesion properties of plasma modified polymers 
are the subject of many studies and much work has been devoted to the enhancement of polymer–polymer, 
metal–polymer adhesion, as well as dyeing and printing on the polymers [24]. A good understanding 
of the surface properties of a solid surface may be obtained relatively inexpensively from the 
measurement of surface contact angle [25]. The surface free energy of a solid is an important 
parameter, playing a vital role in the phenomena that occurs at solid–liquid and solid–gas interfaces. 
Hence, a knowledge of this parameter is useful in studies of adsorption and wettability processes, 
which play important roles in coated drug delivery using polymeric microneedle devices. Measurement 
of the contact angle of the liquid with the solid surface permits a rapid and qualitative evaluation of 
surface free energy of the polymers [26]. 
During the plasma treatment the surface of the polymer is activated, which brings chain session of 
the existing groups on the surface and creates new functional groups like hydroxyl, carboxyl, ether and 
carbonyl which significantly increase the surface free energy. In the recent years there has been a great 
deal of research carried out on plasma methods to modify polymer surfaces for adhesion for medical 
implant applications [27,28]. The role that oxygen plasma treatment of injection moulded polymer 
surfaces can have influence in protein adhesion for drug delivery has yet to be determined in 
significant detail. Hence, in this paper, the possibility of using plasma treatment to improve drug 
adsorption and its release from moulded polymer MNs are studied. 
2. Experimental Section 
2.1. Manufacture of Microneedles and Flat Polymer Samples for Surface Evaluation 
The moulding of the specimens was performed on a Battenfeld Micro-Power 15 (Wittman 
Battenfeld Group, Vienna, Austria) micro-injection moulding machine, using the parameters 
mentioned in the Table 1. 
Table 1. Injection moulding parameters. 
Parameter PEEK PC 
Melt temperature (°C) 420 320
Injection velocity (mm/s) 800 500
Clamping force (kN) 150 100
Time of holding pressure (s) 5 3 
Mould base temperature (°C) 200 120
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The mould for MN manufacture was used to produce specimen for surface evaluation but instead of 
using the MN insert, a flat mould insert and a polished sapphire window (1.5 nm roughness) was used 
on the moving side of the mould. Two candidate materials, Polycarbonate (PC-Lexan HPX8REU) and 
Polyether ether ketone (PEEK, Optima LT-3), were selected for micro-injection moulding. Lexan is 
manufactured by Sabic Innovative Plastics while PEEK LT-3 is FDA approved semi crystalline 
biomaterial launched by Victrex (Invibio Inc., Lancashire, UK). Moulded specimens of each material 
were of 17 mm diameter and 0.5 mm thickness, which was ideal for the surface characterisation. 
Figure 1a shows the top view of the moulded specimen used for surface analysis and Figure 1b shows 
the schematic of the 5 × 5 microneedle array. Microneedles with a shaft length of 550 and 300 µm base 
width and a tip radius of 30 µm in width was manufactured by micro-injection moulding. 
 
Figure 1. Micro-injection moulded samples for (a) flat polymer for surface analysis and  
(b) moulded MN array for dip coating. 
2.2. Oxygen Plasma Treatment 
All the micro-injection moulded samples of PEEK and PC were rinsed with deionised water and air 
dried before the plasma treatment. The plasma treatment system (nano series plasma surface machine 
by Diener electronic, Jettingen, Germany) with a generator that works with radio-frequency signal of  
40 kHz was used for the study. Samples of moulded specimens, which needed plasma activation, were 
placed in the plasma chamber and the vacuum pump was utilised to reduce the pressure to 0.1 mbar 
and at that pressure of the process gas (i.e., oxygen 99% of purity) was fed into the chamber. When 
this working pressure was achieved the generator was switched on and process gas in the recipient was 
ionised. The plasma treatment time was varied between 10, 20, 30, 40, 50, and 60 min. 
2.3. Contact Angle and Surface Energy Analysis 
Flat moulded samples of PEEK and PC were washed and subsequent experimental procedures were 
performed using FTA188 video tensiometer (First Ten Angstroms, Inc., Portsmouth, VA, USA). Static 
contact angle studies were performed using various sets of probe liquids (n-octanol, n-hexane,  
n-octane, n-heptane, cyclohexane, toluene, benzyl alcohol, ethylene glycol, glycerol and double 
distilled water). Practically, droplets (~0.7l of probe liquids) were released on the polymer surface and 
an optical system was used to analyse the drop profile. The contact angle (θ) value was calculated 
using image analysis FTA32 software. Surface free energy (σs) and its polar (σsP) and dispersion (σsD) 
components of the samples were determined from sets of contact angles made by the probe liquids 
according to Owens/Wendt equation. 




= ሺ ߪௌ௉ ሻ ଵ/ଶ ൫ ఙಽ
ು ൯ భ/మ
൫ ఙಽವ ൯ భ/మ
+ሺ ߪௌ஽ ሻ ଵ/ଶ (1)
where σL = surface tension of the wetting liquid, σLD = dispersive component of surface tension of the 
liquid, σLP = polar component of surface tension of the liquid, σs = overall surface energy of the test 
solid, σs D = dispersive component of the surface energy of the solid, σsP = polar component of the 
surface energy of the solid and σsL = interfacial tension between solid and liquid. 
2.4. AFM Analysis 
Atomic force microscope was used to examine the changes in the polymer surface before and after 
the plasma treatment process. All AFM scans were made using an MFP-3D scanner from Asylum 
Research, Santa Barbara, CA, USA. Silicon nitride cantilever tips (Applied Nanostructures, Santa 
Clara, CA, USA) with a tip radius of 15 nm and spring constant of 0.3 Nm were used. The scans were 
made on 10 µm × 10 µm scale and repeated five different times on five different area of the polymer 
film at a resolution of 512 × 512 pixels. Images were interpreted using integrated MFP-3D™ Igor 
software (Asylum Research, Santa Barbara, CA, USA). Errors in the piezo-linearity were corrected for 
by using zero and first order flattening. The scans were made on 10 µm × 10 µm scale and repeated 
five different times on five different area of the flat polymer surface. 
2.5. Surface Morphology after Protein Adsorption 
Protein solution of 50 µg/mL was prepared with lyophilized powder of Bovine Serum Albumin 
(BSA) (Sigma–Aldrich, Dorset, UK) in Phosphate Buffer Solution (PBS) of pH 7.4. Plasma treated 
and untreated polymer samples were immersed in 5 mL protein solution and allowed to incubate at  
37 °C. After 1 h samples were removed from the incubator and rinsed with Milli-Q water to remove 
unbounded protein. All the polymer samples were then allowed to dry at room temperature and 
subsequently analysed by AFM to understand the protein adsorption before and after plasma treatment. 
The scans were made on 1.5 µm × 1.5 µm scale and repeated five different times on five different area 
of the polymer surface. 
2.6. Coating Arrays of Microneedles 
Rows of solid micro-injection moulded MNs were dip coated using an in-house designed nano-
positioning coating device. The coating device consisted of two parts: (1) the micro-positioning dip 
coater and (2) the coating solution reservoir, a schematic of the dip coater is shown in Figure 2a. 
Nano-positioning dip coater: it was designed to restrict access of the coating liquid only to the 
microneedle shaft to prevent contamination of the base, to provide sufficient time to the microneedle 
inside the BSA reservoir and to slowly retract the MNs from the reservoir. To enable three-
dimensional alignment and dipping of microneedle arrays into the reservoir, a piezoelectric nano-
positioner (PZA12) were assembled on a cross-roller linear stage, which hold the microneedle arrays 
(Figure 2b). To view the whole dipping process a Pixelink PL-A776 3.1 mega pixel CMOS colour 
camera coupled with a 2× telecentric lens and a LED fibre optic telecentric illuminator were used. The 
coating was performed automatically using software Lab View (National Instruments, Austin, TX, USA). 
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Coating solution reservoir: The reservoir was custom made of specific dimension from quartz. The 
BSA solution used for dip coating was of a concentration of 10 mg/mL solution. 
 
 
Figure 2. (a) Schematic of the nano-positioner dip coating set up; (b) photograph of dip 
coating apparatus showing individual components; (c) side view showing the lens and the 
BSA reservoir; (d) microneedle array as seen from the software before dip coating. 
2.7. Analysis of BSA in Solution 
BSA analysis was performed using HPLC method with a gradient system that consists of 0.1% 
trifluoroacetic acid in water (A) and 0.08% trifluoroacetic acid in acetonitrile (B) with initial A/B ratio 
of 80/20, which was changed linearly to the final ratio of 35/65 (A/B) within 15 min. The flow rate 
was 1 mL/min and BSA separation was carried out using a Symmetry 300 C4 protein analysis column 
(50 mm× 4.6 mm; 5 µm particle size, Waters, Milford, MA, USA). A UV detector (Waters, USA) at 
wavelength of 220 nm was used for BSA detection. The injection was made using a loop injector 
equipped by a 50 µL loop. A stock solution of BSA of concentration 100 µg/mL was prepared in 
phosphate buffer (pH = 7.4) and various concentrations of 1, 2, 4, 8, 10 and 25 µg/mL were prepared 
by serial diluting the stock solution. These samples were then injected into the HPLC and then linear 
regression analysis was out on known concentration and corresponding peak heights. The regression 
coefficient (r) slope and intercept of the resulting calibration curves were determined. 
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2.8. Drug Release Studies from Microneedles and in Vitro Diffusion Studies 
Passive diffusion of BSA (a water soluble protein with MW 69 KDa) from the polymeric 
microneedle arrays across dermatomed abdominal neonatal porcine skin was investigated in vitro 
using Franz diffusion cells (Copley, Nottingham, UK). Neonatal porcine skin samples were shaved and 
excess fat was removed and pre-equilibrated in phosphate buffer (pH 7.4) for 2 h before the 
experiments. BSA coated MNs were inserted into the circular specimen of skin which was secured to 
the donor compartment of the Franz diffusion cell. It was then placed on top of the receptor cell, which 
was filled with 7 mL of PBS. This complete unit was then mounted on to the Franz cell with 
synchronously stirred using magnetic teflon stir bars at constant speed of 400 rpm and thermostabilised 
at 37 ± 1 °C. A schematic of the experimental setup is shown in Figure 3. At different time points, 
aliquots from the receptor medium was withdrawn from the sampling arm and replaced with fresh 
preheated phosphate buffer pH 7.4 (at 37 °C). The sink condition was maintained throughout the 
experiment and concentration of BSA in the receptor medium was determined using HPLC. The 
cumulative amount of BSA permeated was calculated using PCP disso Software (Pune college of 
Pharmacy, Pune, India). 
 
Figure 3. Schematic of the Franz diffusion experimental setup: (a) vertical diffusion cell; 
(b) exploded view of the cell and sample holder (adapted from www.copley.com). 
2.9. Quantification of the Residual BSA from the MN Shaft after Insertion 
Untreated and plasma treated PEEK and PC microneedles were dip coated with 10 mg/mL of BSA 
for 10 min. These MNs were then inserted into the porcine skin using the thumb pressure and removed 
after 15 min. The MNs after the insertion were transferred to a vial containing 2.5 mL of PBS solution 
and ultra-sonicated to remove the residual BSA on the MNs and the amount of the residual BSA was 
then quantified using the HPLC. 
3. Results and Discussion 
3.1. Plasma Treatment, Contact Angle and Surface Energy 
As expected, the water contact angles made on untreated PEEK (Figure 4a) are larger (above 80°) 
because of the low-energy and hydrophobic nature of the polymer surfaces. The surface used for 
testing contact angle was made by micro-injection moulding having a sapphire window on one side of 
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the mould resulting a very smooth surface. The total surface free energy (polar and dispersive 
component) of the polymer is shown in the Figure 4c. The values of polar and dispersive component of 
the polymer according Owens/Wendt model equation shows that molecular interactions are mainly 
dispersive. The wetting behaviour of the polymer samples were dramatically changed after oxygen 
plasma treatment. It was observed that for both the polymers oxygen plasma treatment lowers the 
contact angle as compared to the untreated samples. Figure 4b shows the water contact angle values for 
untreated and plasma treated polymer samples. This was expected, since the plasma activation process 
more oxygen-containing functional groups of the polymers are generated on the polymer surface 
caused by the reactions between the polymer and active species from the oxygen plasma thus 
increasing the hydrophilicity. Another important factor which increases the wettability is the surface 
modification mechanism by UV radiation emitted by plasma, the exposure to the oxygen plasma 
discharge is sufficient to break chemical bonds (C–C, C–H), and leaves free radicals at or near the 
surface [29]. These radicals can react only with other surface radicals or by chain transfer reaction [30,31]. 
If the polymer surface is flexible, or if the radicals can migrate along it, then recombination, 
unsaturation or cross-linking can occur [32]. Moreover, the plasma removes low molecular weight 
species or converts them to high molecular weight species by cross-linking reaction [33]. In 
summation, the surface of the polymer is activated during plasma treatment, which brings about the 
chain session of the existing groups on the surface of the polymer and creates new functional groups, 
such as –OH and –OOH. 
 
Figure 4. (a) Water contact angle PEEK before and after 10 and 30 min of oxygen plasma 
treatment; (b) graph showing water contact angle with plasma treatment time for PEEK  
and PC; (c) bar graph showing the polar (σP) and dispersive (σD) component of the surface 
energy of the three polymers before and after plasma treatment calculated using 
Owens/Wendt theory. 
3.2. Plasma Treatment and Surface Topography 
The effect of plasma treatment depends on internal and external parameters like type of plasma 
(DC, RF, or microwave), the discharge power density, pressure, and flow rate of the gas or gas mixture 
and exposure time [34]. Oxygen plasma is used to increase polar functional groups (hydroxyl, 
carboxyl, ether, carbonyl, etc.) [27,35], which can successfully increase the surface free energy of the 
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polymer [31]. In the recent years, the surface treatment of polymers has been performed by many 
researchers to make them suitable for adhesion [19,36–38]. 
The morphologies of the two experimental untreated polymeric surfaces are shown in Figure 5a,b, 
as viewed by the AFM. This is a local probe technique that reveals local structural features, which are 
not necessarily representative for the whole sample surface. Due to this reason, an appropriate way to 
record and process many images from different areas of the surface was used. This furnishes local 
structure information with high resolution, but also enables to determine a mean behaviour. The 
representative AFM images of untreated polymer surfaces and scans were made on 10 µm × 10 µm 
scale and repeated five times and average surface roughness was used. All the evaluations that are 
described in the following have, thus been carried out quantitatively and averaged over a large number 
of pictures recorded in different areas of the samples. The mean surface roughness Rq of untreated 
PEEK and PC were 1.51 and 1.61 nm, respectively. This confirms that the surfaces were relatively 
smooth for all polymers, which is important for surface characterisation. 
 
Figure 5. Representative 2D non-contact mode AFM images (10 µm × 10 µm) for 
untreated (a) PEEK and (b) PC; (c,d) surface roughness line profiles for untreated PEEK and 
PC; (e) bar graph showing the surface roughness of each polymer vs. plasma treatment time. 
The AFM images Figures 6 and 7 reveal the surface morphology and the line profiles of the PEEK 
and PC surfaces after plasma treatment for 10, 20, and 30 min respectively. It is well known that the 
wettability of a polymer surface is affected by the surface morphology, especially the surface 
roughness. AFM scans to examine the changes in the surface morphology induced before and after 
oxygen plasma treatment was performed. After the plasma treatment for 30 min showed the presence 
of aggregate structure (sign of patchiness or inhomogeneities) with various sizes on the surface. The 
different sizes of the aggregate indicate the uneven effect of the surface etching by plasma treatment. 
The plasma treatment time was optimised by comparing the contact angle and AFM data. The AFM 
scans showed that after 30 min, further exposure can simply etch away the material that was previously 
modified by the plasma. This can also be the reason for minima and maxima properties as function of 
time, and highlights the importance of optimising the treatment period and to optimise the plasma 
treatment time. Contact angle vs. plasma treatment time was measured and found out that after 30 min 
of plasma there is no significant decrease in the contact angle, as shown in Figure 4b. 
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Figure 6. Representative 2D non-contact mode AFM images (10 µm × 10 µm) and line 
profiles for PEEK after (a) 10, (b) 20, and (c) 30 min of oxygen plasma treatment. 
 
Figure 7. Representative 2D non-contact mode AFM images (10 µm × 10 µm) and line 
profiles for PC after (a) 10, (b) 20, and (c) 30 min of oxygen plasma treatment. 
The plasma treated surfaces of both the polymers also showed the formation of the pit-like 
structures, probably because of sputtering effects of plasma, which was predominantly observed on the 
PC surface. Changes in the surface roughness of the oxygen plasma treated polymer samples were 
quantified by root-mean square values to highlight the surface modifications due to oxygen plasma 
treatment at 30 min. Figure 4c shows average roughness values of untreated and plasma treated 
samples. The average surface roughness increases from 1.51 to 1.61 nm for the untreated PEEK and 
PC, reaching a value of 13.34 and 15.48 nm after 30 min of plasma treatment respectively. This 
indicates that PC surface roughness has slightly increased more than that of PEEK suggesting PEEK to 
be more resistant to plasma treatment as compared to PC [39]. These results are indicative that the 
effects of oxygen plasma treatment on the polymer surface observed by AFM are due to plasma 
bombardment of the surface and scission of the polymeric chains, which in turn rearrange themselves 
to give rise to a new surface morphology [33]. 
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3.3. Plasma Treatment and Protein Adsorption 
Protein adsorption studies to understand the adhesion of BSA on to both treated and untreated 
polymer surfaces were conducted. The 3D AFM image (Figure 8a,b) of both the untreated and treated 
PEEK samples gives a clear understanding of the BSA adsorption at the polymer surfaces. 
 
Figure 8. (a) Representative 3D Tapping mode AFM scans of untreated PEEK + BSA 
showing the how the BSA is adsorbed on a hydrophobic polymer surface; (b) plasma 
treated PEEK + BSA showing the how the BSA is adsorbed on a surface modified  
polymer surface. 
In the case of untreated samples, a patchy pattern of BSA was observed, whereas for plasma treated, 
the BSA was uniformly spread over the entire polymer surface, indicating better adsorption. A protein 
distribution analysis done by the MFP-3D™ Igor software confirmed that 17%–20% of the polymer 
surface was coated with BSA in the case of untreated specimen and thickness of the BSA coat was 
found to be 14.33 ± 3.2 nm. 
3.4. Analysis of BSA 
A high performance liquid chromatography method was used to quantify the BSA adsorbed on the 
polymer surfaces. A calibration curve was obtained for BSA standard solutions of (1, 2, 4, 8, 10 and  
25 µg/mL) (r2 = 0.9985). 





SD Accuracy (%) 
Inter-day    
1 (low) 0.98 0.02 98.62 
50 (medium) 46.45 4.67 92.91 
300 (high) 297.57 1.92 99.19 
Intra-day    
1 (low) 1.034 0.11 96.66 
50 (medium) 48.91 6.84 97.83 
300 (high) 295.13 7.41 98.37 
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Table 2 describes the accuracy and precision of the inter-day and intra-day analyses of three 
different concentration (low, medium, and high) of BSA. The values obtained from the assay 
procedure showed good reproducibility with similar intra-day and inter-day results. A calibration curve 
was used to determine the unknown concentration of BSA adsorbed on to the surface modified 
polymer samples. 
3.5. Quantification of Residual BSA from the MN Shaft after Insertion and in Vitro Delivery of BSA 
across the Neonatal Porcine Skin 
Solid MNs are generally used for proteins and vaccine delivery and the efficiency of these MNs 
depends on how quick the coated formulation is released from MNs to the skin. In this study we 
quantify and compare the residual BSA that is left in the untreated and plasma treated MN shaft after 
insertion onto porcine skin for 15 min. Figure 9a shows the amount of BSA loaded (assay) and residual 
(after insertion) to untreated and treated MNs of PEEK and PC. It is evident that the plasma treated 
MNs could load up to 1 µg of BSA and the residual amount after insertion was found to be 428 ng that 
means 572 ng of BSA was been delivered into the skin in first 15 min whereas in the case of untreated 
MNs could only load 183 ng and the residual amount after insertion was found to be 64 ng which 
means 119 ng of BSA was delivered into skin from the untreated MNs. From this it was observed that 
the amount of BSA loaded was more in the case of plasma treated MNs and just over half the amount 
was released but the in the case of the untreated MNs even though the initial loading was 5.7 times 
over than the plasma treated MNs the proportion of the original amount which was delivered to the 
skin was slightly higher (65% vs. 57.2%). This is because plasma along with increasing the surface 
energy of the polymer surfaces it also increases the adhesion of BSA to the MN shafts resulting in a 
reduced release rate. 
 
Figure 9. (a) Comparison of amount of BSA coated on to the plasma and untreated PEEK 
and PC microneedles and residual BSA from the needle after insertion; (b) comparative 
permeation profiles of BSA across neonatal porcine skin when released from untreated and 
plasma treated MN (PEEK). Means (±SD), n ˃ 3. 
Figure 9b shows the comparative passive permeation of BSA across neonatal porcine skin when 
released from untreated and plasma treated PEEK MNs. The results indicate that the BSA delivery 
from the plasma treated MNs were found to be more efficient than that from untreated MNs. Although 
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plasma treated MNs were able to receive a higher amount of the BSA during coating than untreated 
samples, the total amount of the BSA that could be delivered was limited because of relatively small 
surface area of the MNs. Using BSA as a model drug a maximum of 1 µg of BSA (totally loading 
amount) was coated on 25 plasma treated MNs (550 µm long and 300 µm wide). The plasma treated 
and untreated MNs showed similar release for the initial 6 h and during the 24 h it was found that more 
than 60% of BSA permeated from plasma treated MNs. This is because plasma treatment increases the 
surface energy and enhances BSA adsorption onto the needle shaft. 
4. Conclusions 
This study has demonstrated, for the first time use of plasma treatment in increasing the adsorption 
of BSA onto the MNs shaft for enhanced transdermal delivery. Modification created by plasma 
changed the surface of the microneedles both chemically and morphologically. This resulted in the 
increase of overall surface energy and wettability of the MN surface leading to increase adsorption of 
BSA compared to untreated MNs. 
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